Vendome Acquisition Corporation I

VNMEU · NASDAQ

$10.37+$0.01 (+0.10%)TodayMarket closed ·
No price history for this range.

About VNMEU

Vendome Acquisition Corp.I operates as a blank check company. The company is headquartered in Park City, Utah. The company went IPO on 2025-06-27. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific Business Combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm has no operations and has generated no revenues.

Employees
0
Headquarters
Park City, Utah
Listed
Jun 27, 2025
Sector
N/A
Industry
N/A

VNMEU key statistics

Market cap
258.50M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
65
Volume
500
Open price
$10.40
High today
$10.40
Low today
$10.37
52 Week high
$11.32
52 Week low
$10.10

Vendome Acquisition Corporation I (VNMEU) at a glance

Vendome Acquisition Corporation I (VNMEU) last traded at $10.37, with a market cap of 258.50M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $10.37 and $10.40. The current price is 0.0% above the day's low and 0.3% below its high.

Volume so far is 500 shares, above the average of 65 shares a day.

Over the past year Vendome Acquisition Corporation I has ranged from $10.10 to $11.32, and now sits 22% of the way up that range.

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.